Texas Permanent School Fund Boosts Holdings in Heska Co. (NASDAQ:HSKA)

Texas Permanent School Fund raised its holdings in shares of Heska Co. (NASDAQ:HSKAGet Rating) by 2.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 7,800 shares of the medical research company’s stock after purchasing an additional 206 shares during the quarter. Texas Permanent School Fund’s holdings in Heska were worth $737,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in HSKA. Truist Financial Corp lifted its position in shares of Heska by 13.2% during the first quarter. Truist Financial Corp now owns 4,202 shares of the medical research company’s stock worth $581,000 after purchasing an additional 489 shares during the last quarter. abrdn plc lifted its position in shares of Heska by 0.9% during the first quarter. abrdn plc now owns 330,796 shares of the medical research company’s stock worth $45,742,000 after purchasing an additional 2,976 shares during the last quarter. Envestnet Asset Management Inc. lifted its position in shares of Heska by 18.3% during the first quarter. Envestnet Asset Management Inc. now owns 11,326 shares of the medical research company’s stock worth $1,566,000 after purchasing an additional 1,752 shares during the last quarter. State Board of Administration of Florida Retirement System lifted its position in shares of Heska by 45.4% during the first quarter. State Board of Administration of Florida Retirement System now owns 3,781 shares of the medical research company’s stock worth $523,000 after purchasing an additional 1,180 shares during the last quarter. Finally, Monarch Partners Asset Management LLC bought a new stake in shares of Heska during the first quarter worth $1,549,000. 97.39% of the stock is currently owned by institutional investors.

Heska Price Performance

HSKA opened at $64.00 on Monday. The business’s 50-day moving average is $73.80 and its two-hundred day moving average is $85.55. Heska Co. has a 1 year low of $58.00 and a 1 year high of $189.37. The company has a debt-to-equity ratio of 0.24, a current ratio of 7.18 and a quick ratio of 5.61. The firm has a market capitalization of $692.86 million, a PE ratio of -40.76 and a beta of 1.45.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on HSKA shares. Morgan Stanley decreased their price objective on Heska from $149.00 to $135.00 and set an “equal weight” rating for the company in a report on Wednesday, November 9th. JPMorgan Chase & Co. decreased their price objective on Heska from $175.00 to $150.00 and set an “overweight” rating for the company in a report on Monday, October 17th. Piper Sandler decreased their price objective on Heska from $170.00 to $165.00 and set an “overweight” rating for the company in a report on Monday, November 14th. Alliance Global Partners decreased their price objective on Heska from $155.00 to $119.00 and set a “buy” rating for the company in a report on Wednesday, November 9th. Finally, StockNews.com started coverage on Heska in a report on Wednesday, October 12th. They issued a “hold” rating for the company. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $142.25.

Heska Company Profile

(Get Rating)

Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers.

Read More

Want to see what other hedge funds are holding HSKA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Heska Co. (NASDAQ:HSKAGet Rating).

Institutional Ownership by Quarter for Heska (NASDAQ:HSKA)

Receive News & Ratings for Heska Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska and related companies with MarketBeat.com's FREE daily email newsletter.